Recombinant Human CHRNb2 Protein，His

CHRNb2, or the beta-2 subunit of the nicotinic acetylcholine receptor, has garnered significant attention in biomedical research due to its critical role in neurotransmission and neural signaling. As a part of the ligand-gated ion channel family, CHRNb2 is integral to the modulation of synaptic activity in the nervous system. Alterations or dysfunctions in its expression are associated with various neurological disorders, including addiction, anxiety, and neurodegenerative diseases. Understanding the structure and function of CHRNb2 is essential for developing therapeutic strategies that target these pathways. The recombinant protein expression of CHRNb2 provides a valuable tool for studying its biochemical properties and interactions with other receptor subunits and ligands. By producing this protein in a controlled laboratory environment, researchers can investigate its role in receptor assembly, ion conduction, and cellular signaling processes in detail. Additionally, the availability of CHRNb2 in recombinant form facilitates high-throughput screening of small molecules that may modulate its activity, providing potential avenues for drug discovery. Overall, the study of CHRNb2 recombinant protein is a promising area of research that could enhance our understanding of cholinergic signaling and its implications for treating various neurological conditions.